Platelet alloantigens: cardiovascular as well as immunological risk factors?
- 1 February 1997
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 349 (9049) , 370-371
- https://doi.org/10.1016/s0140-6736(97)80002-5
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Platelet glycoprotein IIIa PlA polymorphism and Japanese diabetic patients with coronary heart diseaseThe Lancet, 1996
- Platelet glycoprotein IIIa gene polymorphism and myocardial infarctionThe Lancet, 1996
- Molecular identification of T cells that respond in a primary bulk culture to a peptide derived from a platelet glycoprotein implicated in neonatal alloimmune thrombocytopenia.Journal of Clinical Investigation, 1996
- Platelet Glycoprotein IIIaPlAPolymorphism and Myocardial InfarctionNew England Journal of Medicine, 1996
- Platelet glycoprotein IIIa PIA polymorphism in young men with myocardial infarctionThe Lancet, 1996
- Clues to the death of an Olympic championThe Lancet, 1996
- A Polymorphism of a Platelet Glycoprotein Receptor as an Inherited Risk Factor for Coronary ThrombosisNew England Journal of Medicine, 1996
- Platelet Glycoprotein IIb/IIIa Receptors in Cardiovascular MedicineNew England Journal of Medicine, 1995
- Human Platelet Alloantigens: Recent Findings, New PerspectivesThrombosis and Haemostasis, 1995
- Nomenclature of human platelet alloantigens: a problem with the HPA system? [see comments]Blood, 1994